Markets:

Overview

News

Currencies

International

Treasuries

Xenon Pharmaceuticals Inc. - Common Shares (NQ:XENE)

41.37 -0.01 (-0.02%)

Streaming Delayed Price Updated: 10:27 AM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Xenon Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 Next >

This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space ↗

February 16, 2024

Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset...

Via Benzinga

4 Analysts Have This to Say About Xenon Pharmaceuticals ↗

December 08, 2023

Via Benzinga

Why Xenon Pharmaceuticals Stock (XENE) Is Seeing Blue Skies Today ↗

November 30, 2023

Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares are trading higher by 7.8% to $36.38 Thursday afternoon. The company announced the pricing of its upsized $300 million public offering of 8,461,542...

Via Benzinga

Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 28, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Xenon Pharma's Depression Candidate Shows Positive Signals Of Efficacy, Despite Primary Endpoint Miss: Analyst ↗

November 27, 2023

Monday, Xenon Pharmaceuticals Inc (NASDAQ: XENE) reported topline results from the Phase 2 proof-of-concept X-NOVA trial, which evaluated the clinical efficacy, safety, and tolerability of 10 mg and 20...

Via Benzinga

Xenon Pharmaceuticals: Q3 Earnings Insights ↗

November 08, 2023

Via Benzinga

Earnings Outlook For Xenon Pharmaceuticals ↗

November 07, 2023

Via Benzinga

Expert Ratings for Xenon Pharmaceuticals ↗

July 17, 2023

Via Benzinga

Analyst Ratings for Xenon Pharmaceuticals ↗

June 15, 2023

Via Benzinga

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 27, 2023

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.

Via Benzinga

The Unexpected Depression Drug News That Sent Xenon Pharmaceuticals Soaring ↗

November 27, 2023

The company's epilepsy drug also showed promise as a depression treatment.

Via Investor's Business Daily

What's Going On With Neurology-Focused Xenon Pharmaceuticals' Stock Today? ↗

November 27, 2023

Xenon Pharmaceuticals Inc (NASDAQ: XENE) reported topline results from the Phase 2 proof-of-concept X-NOVA trial, which evaluated the clinical efficacy, safety, and tolerability of 10 mg and 20 mg of...

Via Benzinga

Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On Monday ↗

November 27, 2023

U.S. stocks traded mostly lower, with the Dow Jones falling around 50 points on Monday. Shares of Ituran Location and Control Ltd. (NASDAQ: ITRN) gained during Monday’s session after the company...

Via Benzinga

Topics Stocks

Xenon Pharmaceuticals: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Where Xenon Pharmaceuticals Stands With Analysts ↗

April 25, 2023

Via Benzinga

Why Is Neurocrine Biosciences Stock Trading Lower Today? ↗

November 10, 2023

Thursday, Neurocrine Biosciences Inc (NASDAQ: NBIX)

Via Benzinga

Earnings Scheduled For November 8, 2023 ↗

November 08, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Xenon Pharmaceuticals Earnings Preview ↗

February 28, 2023

Via Benzinga

The Latest Analyst Ratings for Xenon Pharmaceuticals ↗

January 31, 2023

Via Benzinga

Analyst Ratings for Xenon Pharmaceuticals ↗

December 14, 2022

Via Benzinga

Xenon Pharmaceuticals Earnings Perspective: Return On Capital Employed ↗

December 06, 2022

Via Benzinga

Earnings Scheduled For May 9, 2023 ↗

May 09, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.

Via Benzinga

Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value ↗

April 25, 2023

Cantor Fitzgerald has initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ: XENE) with an Overweight rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023 ↗

April 25, 2023

Via Benzinga

Benzinga Pro's Top 5 Stocks To Watch For Tuesday, April 25, 2023: GM, SNAP, WEN, XENE, CXAI ↗

April 25, 2023

General Motors (GM) - Shares traded about 3% higher Tuesday morning following better-than-expected Q1 earnings and sales and raised guidance. The company said global deliveries of its automobiles

Via Benzinga

Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric ↗

February 02, 2023

The company that remains still has a large pipeline of non-migraine assets.

Via Investor's Business Daily

Applied UV (NASDAQ: AUVI) Effectively Doubles Its Size Following A Merger That Could Help Shape The Industry – A Brief Look At The Company ↗

February 02, 2023

A recent merger between Applied UV Inc. (NASDAQ: AUVI), Puro Lighting (PURO), and LED Supply Co. (LED Supply) seems to have triggered some excitement in the ultraviolet (UV) disinfection equipment...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗

December 12, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.